![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 7
2022
Shah, Bijal D.; Ghobadi, Armin; Oluwole, Olalekan O.; Logan, Aaron C.; Boissel, Nicolas; Cassaday, Ryan D.; Leguay, Thibaut; Bishop, Michael R.; Topp, Max S.; Tzachanis, Dimitrios; O'Dwyer, Kristen M.; Arellano, Martha L.; Lin, Yi; Baer, Maria R.; Schiller, Gary J.; Park, Jae H.; Subklewe, Marion; Abedi, Mehrdad; Minnema, Monique C.; Wierda, William G.; DeAngelo, Daniel J.; Stiff, Patrick; Jeyakumar, Deepa; Dong, Jinghui; Adhikary, Sabina; Zhou, Lang; Schuberth, Petra C.; Faghmous, Imi; Masouleh, Behzad Kharabi und Houot, Roch
(2022):
Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study.
In: Journal of Hematology & Oncology, Bd. 15, Nr. 1, 170
2021
Borchmann, Peter; Plutschow, Annette; Kobe, Carsten; Greil, Richard; Meissner, Julia; Topp, Max S.; Ostermann, Helmut; Dierlamm, Judith; Mohm, Johannes; Thiemer, Julia; Sokler, Martin; Kerkhoff, Andrea; Ahlborn, Miriam; Halbsguth, Teresa V.; Martin, Sonja; Keller, Ulrich; Balabanov, Stefan; Pabst, Thomas; Vogelhuber, Martin; Huttmann, Andreas; Wilhelm, Martin; Zijlstra, Josee M.; Moccia, Alden; Kuhnert, Georg; Brockelmann, Paul J.; Tresckow, Bastian von; Fuchs, Michael; Klimm, Beate; Rosenwald, Andreas; Eich, Hans; Baues, Christian; Marnitz, Simone; Hallek, Michael; Diehl, Volker; Dietlein, Markus und Engert, Andreas
(2021):
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial.
In: Lancet Oncology, Bd. 22, Nr. 2: S. 223-234
Kreissl, Stefanie; Goergen, Helen; Buehnen, Ina; Kobe, Carsten; Moccia, Alden; Greil, Richard; Eichenauer, Dennis A.; Zijlstr, Josee M.; Markova, Jana; Meissner, Julia; Feuring-Buske, Michaela; Soekler, Martin; Beck, Hans Joachim; Willenbacher, Wolfgang; Ludwig, Wol-Dieter; Pabst, Thomas; Topp, Max S.; Hitz, Felicitas; Bentz, Martin; Keller, Ulrich Bernd; Kuehnhardt, Dagmar; Ostermann, Helmut; Hertenstein, Bernd; Ulitzky, Wafter A.; Maschmeyer, Georg; Vieler, Tons; Eich, Hans; Baues, Christian; Stein, Harald; Fuchs, Michael; Diehl, Volker; Dietlein, Markus; Engert, Andreas und Borchmann, Peter
(2021):
PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial.
In: Lancet Haematology, Bd. 8, Nr. 6, E398-E409
Shah, Bijal D.; Ghobadi, Armin; Oluwole, Olalekan O.; Logan, Aaron C.; Boissel, Nicolas; Cassaday, Ryan D.; Leguay, Thibaut; Bishop, Michael R.; Topp, Max S.; Tzachanis, Dimitrios; O'Dwyer, Kristen M.; Arellano, Martha L.; Lin, Yi; Baer, Maria R.; Schiller, Gary J.; Park, Jae H.; Subklewe, Marion; Abedi, Mehrdad; Minnema, Monique C.; Wierda, William G.; DeAngelo, Daniel J.; Stiff, Patrick; Jeyakumar, Deepa; Feng, Chaoling; Dong, Jinghui; Shen, Tong; Milletti, Francesca; Rossi, John M.; Vezan, Remus; Masouleh, Behzad Kharabi und Houot, Roch
(2021):
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study.
In: Lancet, Bd. 398, Nr. 10299: S. 491-502
2020
Zinzani, Pier Luigi; Flinn, Ian W.; Yuen, Sam L. S.; Topp, Max S.; Rusconi, Chiara; Fleury, Isabelle; Le Du, Katell; Arthur, Christopher; Pro, Barbara; Gritti, Giuseppe; Crump, Michael; Petrich, Adam; Samineni, Divya; Sinha, Arijit; Punnoose, Elizabeth A.; Szafer-Glusman, Edith; Spielewoy, Nathalie; Mobasher, Mehrdad; Humphrey, Kathryn; Kornacker, Martin und Hiddemann, Wolfgang
(2020):
Venetoclax-rituximab with or without bendamustine vs bendamustine-rituximab in relapsed/refractory follicular lymphoma.
In: Blood, Bd. 136, Nr. 23: S. 2628-2637
2017
Borchmann, Peter; Goergen, Helen; Kobe, Carsten; Lohri, Andreas; Greil, Richard; Eichenauer, Dennis A.; Zijlstra, Josee M.; Markova, Jana; Meissner, Julia; Feuring-Buske, Michaela; Hüttmann, Andreas; Dierlamm, Judith; Sökler, Martin; Beck, Hans-Joachim; Willenbacher, Wolfgang; Ludwig, Wolf-Dieter; Pabst, Thomas; Topp, Max S.; Hitz, Felicitas; Bentz, Martin; Keller, Ulrich Bernd; Kuhnhardt, Dagmar; Ostermann, Helmut; Schmitz, Norbert; Hertenstein, Bernd; Aulitzky, Walter; Maschmeyer, Georg; Vieler, Tom; Eich, Hans; Baues, Christian; Stein, Harald; Fuchs, Michael; Kuhnert, Georg; Diehl, Volker; Dietlein, Markus und Engert, Andreas
(2017):
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
In: Lancet, Bd. 390, Nr. 10114: S. 2790-2802
Eichenauer, Dennis A.; Plütschow, Annette; Kreissl, Stefanie; Sökler, Martin; Hellmuth, Johannes C.; Meissner, Julia; Mathas, Stephan; Topp, Max S.; Behringer, Karolin; Klapper, Wolfram; Kuhnert, Georg; Dietlein, Markus; Kobe, Carsten; Fuchs, Michael; Diehl, Volker; Engert, Andreas und Borchmann, Peter
(2017):
Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.
In: Lancet Oncology, Bd. 18, Nr. 12: S. 1680-1687